HIMSS TV is your Insider’s Guide to everything HIMSS. We are the world’s first online broadcasting network, focused on global innovation and how information and technology are driving change in healthcare.
Jerry Shultz, president at Lightbeam Health Solutions, talks about how the company uses predictive analytics and AI to help payers and health systems determine patients' risk profiles and assign them to the most appropriate care path.
Cody Coonradt, CEO and founder of Billy, discusses how patients, advocates and insurance agents use the company's app, which displays hospital pricing data by location, to negotiate prices for medical procedures.
Felix Lee, head of organizational capability and transformation at Sanofi, relays how the pharma company leverages DarioHealth's digital therapeutics to complement its drug offerings and gather a comprehensive picture of a patient's health.
Amos Adler, founder, and president at Memotext, discusses his company's flagship digital app for the schizophrenia and psychosis population and how its portal helps caregivers engage with patients and identify the risks for relapse and readmission.
Lyle McMillin, principal product manager at Hyland, says the company's recent survey with HIMSS Market Insights found that many healthcare organizations are still struggling to exchange patient data, even after moving to the cloud.
Dr. Zsolt Kulcsar, Lee Health's systems medical director of virtual health, discusses his team's RPM successes, including an automated system that refers chronic heart failure patients discharged from Lee hospitals to his department.
Heidi Veltman, VP & COO of Kaiser Permanente Georgia, says next-generation imaging enhances treatments by providing crisper scans, creating better patient experience, improving diagnostic visibility and reducing duplication.
Jack Clough, chief growth officer at Celo, talks about the company's HIPAA-compliant clinical messaging app, which allows care teams to share information easily without compromising patient privacy.
Gaurav Sharma, senior director, global client partner at Cognizant, says sharing real-world patient data with life sciences organizations could help optimize clinical trials and drive discoveries in precision medicine.
Steven Walther, cofounder and CEO of Continuous Precision Medicine, discusses how the company's collected data assists providers in ensuring the appropriate amount of pain medication is administered to patients for pain management.
Tabia Health cofounders, CEO Steve Pickett and president Ricardo Clemente, discuss the company's AI-powered complex chronic disease management platform, which nearly doubles treatment adherence rates.
Dr. Jeffrey Chen, clinical advisor at No Barrier AI, discusses the company's AI-driven, clinically trained app, which translates spoken words into multiple languages to help patients and clinicians communicate more effectively for better treatment.